[1] |
Scales CD Jr, Smith AC, Hanley JM, et al. Prevalence of kidney stones in the United States [J]. Eur Urol, 2012, 62(1): 160-165.
|
[2] |
黄健. 中国泌尿外科和男科疾病诊断治疗指南: 2019版[M].北京: 科学出版社, 2020, 246-248.
|
[3] |
Strohmaier WL. Course of calcium stone disease without treatment. What can we expect? [J]. Eur Urol, 2000, 37(3): 339-344.
|
[4] |
Li B, Tang Y, Zhou L, et al. Association between aortic calcification and the presence of kidney stones: calcium oxalate calculi in focus [J]. Int Urol Nephrol, 2022, 54(8): 1915-1923.
|
[5] |
Ferraro PM, Marano R, Primiano A, et al. Stone composition and vascular calcifications in patients with nephrolithiasis [J]. J nephrol, 2019, 32(4): 589-594.
|
[6] |
Hsi RS, Spieker AJ, Stoller ML, et al. Coronary artery calcium score and association with recurrent nephrolithiasis: the multi-ethnic study of atherosclerosis [J]. J Urology, 2016, 195(41): 971-976.
|
[7] |
Stern KL, Ward RD, Li J, et al. Nonrenal systemic arterial calcification predicts the formation of kidney stones [J]. J Endourol, 2019, 33(12): 1032-1034.
|
[8] |
Patel ND, Ward RD, Calle J, et al. Vascular disease and kidney stones: abdominal aortic calcifications are associated with low urine pH and hypocitraturia [J]. J Endourol, 2017, 31(9): 956-961.
|
[9] |
Tzelves L, Türk C, Skolarikos A. European Association of Urology Urolithiasis Guidelines: Where Are We Going? [J]. Eur Urol focus, 2021, 7(1): 34-38.
|
[10] |
Lee JY, Andonian S, Bhojani N, et al. Canadian Urological Association Guideline: management of ureteral calculi[J]. Can Urol Assoc J, 2021, 15(12): 1676-1690.
|
[11] |
Assimos D, Krambeck A, Miller NL, et al. Surgical management of stones: American Urological Association/Endourological Society Guideline, PART I [J]. J Urol, 2016, 196(4): 1153-1160.
|
[12] |
Shavit L, Girfoglio D, Vijay V, et al. Vascular calcification and bone mineral density in recurrent kidney stone formers [J]. Clin J Am Soc Nephrol, 2015, 10(2): 278-285.
|
[13] |
Reiner AP, Kahn A, Eisner BH, et al. Kidney stones and subclinical atherosclerosis in young adults: the CARDIA study [J]. J Urology, 2011, 185(3): 920-925.
|
[14] |
Maddahi N, Aghamir SMK, Moddaresi SS, et al. The association of Dietary Approaches to Stop Hypertension-style diet with urinary risk factors of kidney stones formation in men with nephrolithiasis [J]. Clin Nutr ESPEN, 2020, 39(12): 173-179.
|
[15] |
Kohjimoto Y, Sasaki Y, Iguchi M, et al. Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan [J]. Am J Kidney Dis, 2013, 61(6): 923-929.
|
[16] |
Moreira DM, Friedlander JI, Hartman C, et al. Association of estimated glomerular filtration rate with 24-h urinalysis and stone composition [J]. Urolithiasis, 2016, 44(4): 319-325.
|
[17] |
Liu CJ, Cheng CW, Tsai YS, et al. Crosstalk between renal and vascular calcium signaling: the link between nephrolithiasis and vascular calcification [J]. Int J Mol Sci, 2021, 22(7): 3590-3605.
|
[18] |
Eisner BH, Porten SP, Bechis SK, et al. Hypertension is associated with increased urinary calcium excretion in patients with nephrolithiasis [J]. J Urology, 2010, 183(2): 576-579.
|
[19] |
Khan SR. Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome? [J]. Urol Res, 2012, 40(2): 95-112.
|
[20] |
Kim YJ, Park MS, Kim WT, et al. Hypertension influences recurrent stone formation in nonobese stone formers [J]. Urology, 2011, 77(5): 1059-1063.
|
[21] |
武佰锁, 郭君毅, 王锦波. 代谢综合征与肾结石的相关性研究进展[J]. 微创泌尿外科杂志, 2019, 8(04): 280-286.
|
[22] |
陈城, 李翔翔, 胡林昆, 等. 血脂异常与泌尿系结石形成的相关性研究[J]. 中华泌尿外科杂志, 2016, 37(09): 698-702.
|
[23] |
Ding Q, Ouyang J, Fan B, et al. Association between Dyslipidemia and Nephrolithiasis Risk in a Chinese Population [J]. Urologia internationalis, 2019, 103(2): 156-165.
|
[24] |
徐宏博, 魏雪栋, 胡林昆, 等. 内脏脂肪面积与尿酸结石形成的相关性研究[J]. 中华泌尿外科杂志, 2019, 40(2): 105-110.
|
[25] |
王乾, 李殷南, 孙宾, 等. 崇明地区泌尿系结石成分分析及与血尿酸的相关性[J]. 国际泌尿系统杂志, 2021, 41(3): 487-491.
|